
feb pm et
summari form merger quintil contract research organ im
provid prescript electron health record data
nm price-to-earnings oper ep
risk assess account market leadership
posit compani well demand see
healthcar data drug develop
fiscal year end dec ep estim base cfra
oper earn histor earn report
cash dividend paid last year
past perform indic futur perform reli upon
analysi prepar equiti analyst
feb pm stock trade
look sale januari
adopt revenu recognit
standard new standard
recogn revenu unit
percentag complet basi
standard requir servic revenu
reimburs expens revenu treat
consist present one line
revenu re-cast
revenu would look sale
commerci solut unit grow
 rise integr
octob im health quintil
transnat merg deal
merger combin largest contract research
organ one largest provid
data servic drug
chairman ceo quintil tom pike
vice chairman presid
solut compani geograph
divers client base america
europ middl east africa
asia pacif novemb
compani chang name quintilesim
iqvia
ep estim
although believ merger provid
robust end-to-end data technolog
offer drug firm neutral view
deal anticip modest sale
cost synergi manag forecast
modest increment annual sale
growth million annual run-rat
cost save end year three
believ share trade
ep estim line peer near fair
new busi month
end decemb book-to-bil
drive backlog
decemb view highli
leverag net debt/ebitda
sale cost save synergi
slowdown outsourc spend
target base
line peer ep estim
account integr challeng
modest sale cost save synergi
howev see ep aid stock
buy-back program repurchas
billion stock post-merg current
remain stock buy-back
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
chief offic
offic presid
presid corpor
gener counsel
quintilesim hold inc form octob merger quintil transnat
lead contract research organ im health lead provid prescript electron
health record data combin compani lead integr inform technolog healthcar
servic provid novemb quintilesim chang name iqvia
quintil provid biopharmaceut develop servic commerci outsourc servic
conduct busi approxim countri quintil offer servic two segment
product develop integr healthcar servic product develop provid servic
expertis enabl biopharmaceut compani outsourc clinic develop process
first-in-man clinic trial post-launch monitor product develop compris clinic
solut servic consult clinic solut provid servic necessari develop
biopharmaceut product includ project manag clinic monitor function
conduct multi-sit clinic trial gener phase ii-iv clinic trial support servic
improv clinic trial decision-mak data manag strateg plan design servic
improv decis perform consult provid strategi manag consult
servic base deep life scienc expertis advanc analyt well regulatori complianc
consult servic clinic solut servic enabl conduct coordin multi-sit
clinic trial gener phase ii-iv servic offer includ protocol design feasibl
oper plan site start patient recruit project manag monitor
investig site data patient visit
im oper inform technolog servic compani provid client healthcar
industri solut measur improv perform world-wide compani
collect healthcar inform world span sale prescript promot data
medic claim electron medic record social media compani data set contain
approxim petabyt data approxim million longitudin anonym patient
record record link time anonym individu across healthcar set
compani presenc approxim countri
compani serv key healthcar organ decis maker world-wide span breadth
life scienc compani includ pharmaceut biotechnolog consum health medic devic
manufactur well distributor provid payer govern agenc policymak research
financi commun
compani princip inform offer compris nation inform offer approxim
countri provid consist countri level perform metric relat sale pharmaceut
product prescrib trend medic treatment promot activ across multipl channel
includ retail hospit mail order product integr part critic process life
scienc compani world-wide also use extens invest financi sector
deal life scienc compani client use product measur rel perform assess
market opportun determin brand compani strategi understand market dynam
product avail rang frequenc weekli annual deliv variou
format includ on-line host pc mobil platform
compani sub-nat offer compris servic approxim countri provid
consist measur sale prescrib activ region zip code individu prescrib
depend regul countri product use extens major
pharmaceut sale organ within countri depend servic set goal
determin resourc measur perform calcul compens compani onekey
refer databas track approxim million healthcar profession countri provid
view health care practition critic commerci success market sale
compani also provid rang cloud-bas applic associ implement servic
saa solut support rang commerci regulatori process includ multi-channel
territori align roster manag call plan complianc report master data
manag solut use healthcar compani manag optim execut
commerci strategi orchestr manner meet regulatori oblig use
proprietari algorithm compani combin country-level data healthcar expertis therapeut
knowledg approxim countri creat global market insight famili offer
mida analyt link diseas insight provid major sourc insight intern
market dynam use larg pharmaceut compani
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
overvalu
neutral sinc februari technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
posit fundament outlook
life scienc tool servic sub-industri
next month may congress
approv billion increas nation
institut nih fy budget
billion septemb
billion increas fy budget
increas contrast presid
trump call cut nih budget
billion billion fy fy
signific fund academ lab
turn account sale life
scienc tool compani averag
trump propos indic
administr prioriti actual fund
determin congress think
signific bipartisan support nih
believ congress disregard trump propos
cut nih budget nonetheless trump
propos budget creat uncertainti
may result project termin
cloud futur research project
view nih budget rose
billion billion
largest percentag increas sinc
includ billion stimulu fund
american recoveri reinvest act
arra
howev note mani life scienc
compani activ pursu initi
commerci non-academ govern
revenu base also see budget issu
europ result soft govern fund
decemb presid obama sign
centuri cure act law law
provid billion year
nation institut split
go cancer moonshot billion
fund precis medicin initi
billion fund brain initi
support alzheim diseas research
overal see mid-single-digit sale growth
emerg market
china remain robust growth region
grow double-digit rate help fuel
overal industri growth believ demand
strong begin moder
think research lab suffici
equip current need mani
equip compani also diversifi
product line increas sale
consum typic immun
budget constraint expand
area environment food
safeti agricultur growth
end-market expect robust
pharmaceut research
compani provid servic
pharmaceut biotech firm
contract research organ see
solid growth next month
view believ pharmaceut biotech
firm increasingli outsourc servic
think increas effici lower
cost also see increas strateg
 life scienc tool
 composit index year date
decemb life
rise composit
base index
five-year market price perform feb
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
/jeffrey loo cfa
quintil im hold inc keep target
price slightli peer ep estim account
modest sale cost save synergi sinc merger quintil
im health complet octob compani provid
result stand-alone basi quintil ep vs
ahead estim servic revenu rose product develop rose
im sale rose combin basi see sale
ep contract backlog billion septemb
hold hold opinion initi coverag
share quintil im technolog data healthcar provid hold
recommend although believ merger quintil im provid
robust end-to-end data inform offer drug firm
neutral view merger anticip modest sale cost save
synergi also anticip integr challeng merger
equal forecast ep
target price base slightli peer ep
analyst research note compani news
et cfra keep hold opinion share ia hold
rais target line peer
ep estim set ep
vs ahead estim pro-forma sale rose
commerci solut research develop solut
integr engag servic fell guid sale
re-cast sale adopt
revenu recogn percentag complet basi
reimburs expens treat consist servic revenu /jeffrey
februari iqvia hold inc announc appoint eric
sherbet execut vice presid gener counsel compani
effect march mr sherbet bring year relev
experi new role recent serv gener counsel
secretari patheon oversaw compani initi public
offer recent acquisit thermo fisher date
compani announc jame erling execut vice presid gener
counsel secretari compani retir offic employe
compani effect februari
quintilesim announc appoint colleen goggin board
director effect juli senior execut johnson
johnson three decad goggin retir serv ten
year js execut committe world-wide chairman
consum group goggin member supervisori board bayer ag
member board director td bank group goggin also
member univers wisconsin foundat serv board
director univers wisconsin center brand product
manag child health institut new jersey institut
intern educ new york citi meals-on-wheel
quintilesim announc tim sheppard gener manag taken new
respons see lead quintilesim engag uk
regul govern industri bodi follow merger quintil
im last year sheppard overse evolut unifi
compani cultur also facilit collabor across broad rang
capabl also lead on-going integr activ sheppard
work quintilesim sinc join gener manag im
uk ireland prior join compani led healthcar
sector unipart expert practic serv director public sector
servic among variou role
hold inc keep target
in-lin peer ep estim ep vs
estim sale reflect merger im
rose pro forma basi research develop
solut sale rose commerci solut sale rose
slightli forecast view new busi sign past
month drive backlog solid repurchas
billion share quarter million remain buy-back
quintil im hold inc rais target
in-lin peer ep estim
set ep estim ep vs
ahead estim sale reflect merger im health rose
pro forma basi commerci solut sale rose
solut integr engag servic fell guid
sale ep backlog
sign last month compani increas stock buy-back
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
